DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Digoxin
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: United States Department of Defense